Understanding the Human Playbook
With a $5.6 million grant from the Tow Foundation, HSS created The David Z. Rosensweig Genomics Research Center, under the direction of Associate Chief Scientific Officer Dr. Lionel Ivashkiv. The goals are to define the regulation of genes associated with autoimmune and inflammatory diseases, and to develop more effective therapies for rheumatoid arthritis and systemic lupus erythematosus. Learn more
Dr. Scott Rodeo is co-Principal Investigator of a grant from the Arthritis Foundation to validate the use of new MRI techniques and biomarkers to identify the early signs of Osteoarthritis (OA) in patients who have had ACL tears and other sports injuries. In collaboration with investigators at the University of California-San Francisco and the Mayo Clinic in Rochester Minnesota, Dr. Rodeo and HSS colleagues in radiology, orthopaedics and basic science are developing tools to predict a patient’s risk of developing OA and determining the most effective therapeutic interventions. Read More
Using the Past to Improve the Future
The Hospital’s new Healthcare Research Institute (HRI), under the leadership of Dr. Stephen Lyman, is leveraging the enormous breadth of clinical information available at HSS- where more than 29,000 surgeries and 330,000 outpatient visits were conducted last year- to translate informed outcomes into better treatments for patients. Learn more
Dr. Jane Salmon leads a multi-center research initiative, the PROMISSE study, to identify predictors of poor pregnancy outcomes in women with systemic lupus erythematosus (SLE). The study is providing insights on the genes and cellular pathways that can affect pregnancy in lupus patients and, potentially, cause miscarriage and preeclampsia in healthy women. Learn More
Revision total hip arthroplasty (THA) is associated with increased cost, morbidity, and technical challenge compared to primary THA. Patient databases from 2 states (California and New York), analyzed to evaluate the influence of patient-, community-, and hospital-related characteristics on the risk of early revision THA, demonstrated that that early revision THA is more common in patients who undergo primary THA at low-volume hospitals. Learn More
Essential to Hospital for Special Surgery’s leadership in breakthrough research are its physician-scientists, who balance clinical care with the rigorous pursuit of medical research. HSS has established the Anna-Maria and Stephen Kellen Physician-Scientist Career Development Award program to cultivate the next generation of physician/scientists, The Anna-Maria and Stephen Kellen Foundation has provided $4.3 of support. Learn More
Funding from the National Institute of Arthritis and Musculoskeletal and Skin Diseases provides support for the HSS Rheumatology Research Training Program and the Musculoskeletal Research Training Program to mentor and guide the academic careers of pre- and post-doctoral fellows in basic research and clinical research disciplines.
Suzanne Maher, PhD
Marjolein van der Meulen, PhD
Dr. Suzanne Maher, Associate Scientist and Associate Director of the HSS Tissue Engineering, Regeneration and Repair Program, and Dr. Marjolein van der Meulen, Associate Scientist, HSS Musculoskeletal Integrity Program and Chair, Department of Biomedical Engineering at Cornell University, are principal investigators of the recently renewed Musculoskeletal Training Program currently in its 31st year of funding.
Mary Crow, MD
Dr. Mary Crow, Senior Scientist and Physician-in-Chief, is principal investigator of the Rheumatology Training Program, currently in its 29th year of funding.
Dr. Mary Goldring, senior scientist, was named President of the Orthopaedic Research Society (ORS). The inauguration took place at the ORS annual meeting in New Orleans, with more than 2600 attendees. Learn More
Dr. Mathias Bostrom, senior clinician scientist, was named 1st Vice President of ORS.
Dr. Jo Hannafin, senior clinician scientist, became the first female President of the American Orthopedic Society for Sports Medicine. Learn More
This honor recognizes scientists whose sustained research has translated into novel therapies and improved patient care, and who serve as role models for advocacy in funding for musculoskeletal research. Learn More
HSS currently receives more than $12 million annually in grants from the National Institutes of Health (NIH) to support basic and clinical research activities. In addition, research is supported by grants from the Arthritis Foundation, Orthopaedic Research and Education Foundation, Alliance for Lupus Research, Lupus Research Institute, Rheumatology Research Foundation, Leukemia and Lymphoma Society and others. Learn more